Taisuke Mori

5.5k total citations
143 papers, 3.1k citations indexed

About

Taisuke Mori is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Taisuke Mori has authored 143 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Oncology, 40 papers in Surgery and 36 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Taisuke Mori's work include Sarcoma Diagnosis and Treatment (18 papers), Head and Neck Cancer Studies (17 papers) and Ear and Head Tumors (11 papers). Taisuke Mori is often cited by papers focused on Sarcoma Diagnosis and Treatment (18 papers), Head and Neck Cancer Studies (17 papers) and Ear and Head Tumors (11 papers). Taisuke Mori collaborates with scholars based in Japan, United States and United Kingdom. Taisuke Mori's co-authors include Michiie Sakamoto, Akihiro Umezawa, Tohru Kiyono, Satoshi Ogawa, Seiichi Yoshimoto, Kaoru Segawa, Yae Kanai, Wenlin Du, Hitoshi Ichikawa and Hideaki Imabayashi and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Taisuke Mori

133 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Taisuke Mori Japan 31 1.1k 895 820 525 496 143 3.1k
Yukio Takeshima Japan 34 941 0.8× 773 0.9× 494 0.6× 1.4k 2.8× 468 0.9× 168 3.4k
Torsten E. Reichert Germany 37 1.6k 1.5× 1.3k 1.5× 858 1.0× 264 0.5× 398 0.8× 150 4.8k
Riccardo Ferracini Italy 33 1.3k 1.1× 872 1.0× 619 0.8× 455 0.9× 185 0.4× 92 3.0k
Bruno Delorme France 24 1.0k 0.9× 517 0.6× 783 1.0× 422 0.8× 1.6k 3.2× 34 3.1k
Ralf Huss Germany 35 1.1k 1.0× 971 1.1× 907 1.1× 313 0.6× 1.4k 2.9× 111 3.9k
Charles K. F. Chan United States 26 1.5k 1.4× 1.1k 1.2× 419 0.5× 332 0.6× 690 1.4× 59 4.2k
Yo Mabuchi Japan 31 1.4k 1.3× 610 0.7× 804 1.0× 262 0.5× 1.6k 3.3× 81 3.7k
Jean‐Jacques Lataillade France 31 999 0.9× 773 0.9× 995 1.2× 281 0.5× 1.8k 3.7× 79 3.9k
Balkrishna Jahagirdar United States 13 1.2k 1.1× 821 0.9× 613 0.7× 497 0.9× 854 1.7× 22 2.5k
Daniel J. Ceradini United States 22 1.3k 1.2× 787 0.9× 1.3k 1.6× 284 0.5× 766 1.5× 58 3.7k

Countries citing papers authored by Taisuke Mori

Since Specialization
Citations

This map shows the geographic impact of Taisuke Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taisuke Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taisuke Mori more than expected).

Fields of papers citing papers by Taisuke Mori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taisuke Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taisuke Mori. The network helps show where Taisuke Mori may publish in the future.

Co-authorship network of co-authors of Taisuke Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Taisuke Mori. A scholar is included among the top collaborators of Taisuke Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taisuke Mori. Taisuke Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mori, Taisuke, et al.. (2025). Glucose deprivation induces cisplatin resistance through upregulation of SLC7A11 (xCT) expression in endometrial cancer cells. Biochemical and Biophysical Research Communications. 766. 151887–151887. 1 indexed citations
2.
Kojima, Naoki, Tetsuro Taki, Tomohiro Miyoshi, et al.. (2024). Inflammatory spindle cell PEComa of the lung with YAP1::TFE3 fusion: a report of two cases and a potential relationship with clear cell stromal tumour. Histopathology. 86(3). 365–372. 5 indexed citations
4.
Kobayashi, Kenya, Yoshitaka Honma, Eijitsu Ryo, et al.. (2023). Clinical and pathological features of second primary neoplasms arising in head and neck reconstructive skin flaps. Scientific Reports. 13(1). 11214–11214. 3 indexed citations
5.
Motoi, Toru, Makoto Hirata, Yoji Kukita, et al.. (2023). KDM2B-Rearranged Soft Tissue Sarcomas Expand the Concept of BCOR-Associated Sarcoma. Modern Pathology. 36(11). 100317–100317. 1 indexed citations
6.
Kashihara, Tairo, Taisuke Mori, Satoshi Nakamura, et al.. (2023). Correlation between L‐amino acid transporter 1 expression and 4‐borono‐2‐18F‐fluoro‐phenylalanine accumulation in humans. Cancer Medicine. 12(21). 20564–20572. 6 indexed citations
7.
Iwata, Shintaro, Kaishi Satomi, Taisuke Mori, et al.. (2023). Keratin‐positive fibrotic extraskeletal myxoid chondrosarcoma: a close mimic of myoepithelial tumour. Histopathology. 82(6). 937–945. 3 indexed citations
8.
Omura, Go, Kenjiro Namikawa, Toshihiko Sakai, et al.. (2023). Clinical outcomes of head and neck mucosal melanoma treated with surgery: a single-center study in Japan. Japanese Journal of Clinical Oncology. 53(11). 1045–1050. 1 indexed citations
9.
Yoshida, Akihiko, et al.. (2023). Case Report: Painful EWSR1::SMAD3-Positive fibroblastic tumor invading bone. 2(4). 188–191. 1 indexed citations
10.
Ryo, Eijitsu, Satoshi Inoue, Masahito Kawazu, et al.. (2023). Strategic Approach to Heterogeneity Analysis of Cutaneous Adnexal Carcinomas Using Computational Pathology and Genomics. SHILAP Revista de lepidopterología. 3(6). 100229–100229. 1 indexed citations
11.
Kashihara, Tairo, Dai Ogata, Kae Okuma, et al.. (2022). Clinical significance of local control of primary tumour in definitive radiotherapy for scalp angiosarcomas. Skin Research and Technology. 29(1). e13243–e13243. 3 indexed citations
12.
Naito, Yutaka, Nami Miura, Taisuke Mori, et al.. (2022). RIOK2 Contributes to Cell Growth and Protein Synthesis in Human Oral Squamous Cell Carcinoma. Current Oncology. 30(1). 381–391. 2 indexed citations
13.
Muto, Yusuke, Eijitsu Ryo, Kenjiro Namikawa, et al.. (2021). RB1 gene mutations are a distinct predictive factor in Merkel cell carcinoma. Pathology International. 71(5). 337–347. 5 indexed citations
14.
Ikegami, Masachika, Shinji Kohsaka, Takeshi Hirose, et al.. (2021). MicroSEC filters sequence errors for formalin-fixed and paraffin-embedded samples. Communications Biology. 4(1). 1396–1396. 5 indexed citations
15.
Shiraishi, Kouya, Yuki Shinno, Yoshihisa Kobayashi, et al.. (2021). An Alert to Possible False Positives With a Commercial Assay for MET Exon 14 Skipping. Journal of Thoracic Oncology. 16(12). 2133–2138. 12 indexed citations
16.
Yoshida, Akihiko, Yasuhito Arai, Kaishi Satomi, et al.. (2021). Identification of novel SSX1 fusions in synovial sarcoma. Modern Pathology. 35(2). 228–239. 25 indexed citations
17.
Miura, Nami, Yuki Sugiura, Yuichi Abe, et al.. (2021). Possible Therapeutic Strategy Involving the Purine Synthesis Pathway Regulated by ITK in Tongue Squamous Cell Carcinoma. Cancers. 13(13). 3333–3333. 7 indexed citations
18.
Makise, Naohiro, Taisuke Mori, Hiroshi Kobayashi, et al.. (2020). Mesenchymal tumours with RREB1–MRTFB fusion involving the mediastinum: extra‐glossal ectomesenchymal chondromyxoid tumours?. Histopathology. 76(7). 1023–1031. 10 indexed citations
19.
Kobayashi, Kenya, Seiichi Yoshimoto, Mizuo Ando, et al.. (2020). Full-coverage TP53 deep sequencing of recurrent head and neck squamous cell carcinoma facilitates prognostic assessment after recurrence. Oral Oncology. 113. 105091–105091. 7 indexed citations
20.
Toki, Shunichi, Susumu Wakai, Masaya Sekimizu, et al.. (2018). PAX7 immunohistochemical evaluation of Ewing sarcoma and other small round cell tumours. Histopathology. 73(4). 645–652. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026